
Reconstitution

Energy & Longevity · 10mg
CAS 727490-83-3
SS-31, formally elamipretide and also written SS31, is a mitochondria-targeted tetrapeptide studied for mitochondrial function, redox balance, exercise-tolerance, and cellular-energy research. It is distinctive for concentrating at the inner mitochondrial membrane, where it associates with the phospholipid cardiolipin, and it is studied for how that localisation influences mitochondrial-energy pathways in preclinical models. The 10mg vial is the standard reference format.In preclinical and in-vitro research, elamipretide is investigated for its interaction with cardiolipin and the electron-transport and redox pathways of the mitochondrion. Its mitochondrial-targeting is the defining research characteristic and the reason it occupies its own place in the cellular-energy literature.SS-31 sits in the energy-and-longevity family alongside NAD+ and MOTS-c, the three most-studied cellular-energy references in the range; researchers building a mitochondrial-research plan often look at them together. Our NAD+ and cellular energy library guide covers the pathways they are studied for. The 10mg vial here is the clean single-compound reference for elamipretide.Every 10mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the inside wall of the vial, swirl gently, and never shake. Store the unopened vial at 2 to 8°C; refrigerate once reconstituted and do not refreeze. CAS reference 727490-83-3.Buying SS-31 (elamipretide) in Australia is domestic: free Australia Post Express shipping to every state and territory, no minimum spend, dispatch from within Australia, and tracking on every parcel. Checkout accepts card, PayPal, or PayID, each vial is sealed under argon, and a 24-hour reservation holds your stock from order. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.
SS-31 carries 258 indexed publications, 29 registered trials, 1 with Australian sites, 1,644 monthly readers on Wikipedia. Research activity sits at 46 papers in the past twelve months against 28 the year before.
Mitochondrial and cardioprotection-adjacent searches from advanced longevity researchers.
258 papers, 46 this year · 29 trials, 1 in Australia · 1,644 readers (-28%) · A tier
Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.
Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.
SS-31 10mg arrives sealed and research-ready, with a written preparation and storage card in every order. Prepare and store it as set out below, and use the reconstitution calculator to work out your concentration and draw volume before you begin.
Your SS-31 10mg vial arrives securely packaged. Refrigerate it sealed at 2–8°C until you are ready to prepare.
Add Bacteriostatic Water slowly against the vial wall, then swirl gently. Never shake.
Once prepared, aliquot and freeze at −20°C. Avoid repeated freeze–thaw cycles.
“Well sealed and well packed. Express tracking the whole way.”
“Clean presentation and quick dispatch. Delivery ran to the full estimate but tracked fine.”
Educational and product-logistics information only. Nothing here is medical advice or a therapeutic claim.
The coenzyme at the centre of cellular energy, what NAD+ is, how it differs from a peptide, and why it sits in the cellular-energy family.
Read →A simple decision framework, start with the goal, let the goal narrow the family, and let the family narrow the compound.
Read →The single most important document in peptide research, what a COA is, what to look for, and why we ship one with every vial.
Read →Also Searched As·SS-31 is also searched as Elamipretide, SS31, SS 31, Bendavia, Elamipretide peptide.
SS-31 appears in 258 indexed publications going back to 1993, including 46 in the past twelve months. 29 registered trials appear on ClinicalTrials.gov, 1 with Australian sites.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 7 |
|---|---|
| 2016 | 10 |
| 2017 | 13 |
| 2018 | 16 |
| 2019 | 20 |
| 2020 | 21 |
| 2021 | 23 |
| 2022 | 18 |
| 2023 | 19 |
| 2024 | 20 |
| 2025 | 32 |
| 2026 | 35 |